OLD amputates the anticodon arm of tRNAs during P2–Lambda interference
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf874 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Apurva A Govande und 9 weiteren Autor:innen. Beteiligte Einrichtung: New England Biolabs, 240 County Road, Ipswich, MA 01938, United States. Hauptthemen laut MEDLINE: Anticodon, RNA, Transfer, Viral Proteins, Bacteriophage lambda. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Science Foundation Center for Physics of Living Cells, NIH HHS, National Science Foundation Science and Technology Center for Quantitative Cell Biology.
Abstract (Originalsprache)
ATPase-coupled Toprim (Topoisomerase-primase) nucleases, known as Overcoming Lysogenization Defect (OLD) proteins, are crucial for diverse antiphage defenses. The first OLD protein was discovered in phage P2 in 1970 as the factor responsible for executing P2–Lambda interference. In this classic phage conflict, P2–OLD halts phage Lambda replication in host cells carrying the P2 prophage by causing cell death through a poorly understood mechanism. We discovered P2–OLD causes cell death by degrading host threonyl–tRNA with the UGU anticodon (tRNAThrU). Phage-encoded threonyl–tRNAs with the same anticodon rescued P2–OLD-induced cell death by replacing the degraded host version. Our analysis revealed that P2–OLD cleaves tRNAs containing a paired pseudo-palindromic CNG motif in the anticodon stem, with a preference for tRNAThrU. P2–OLD cuts after the cytosine within the CNG motif on both strands, resulting in a staggered cut that detaches the anticodon stem. Phage threonyl–tRNAs resist P2–OLD cleavage due to CNG motif alterations and a shorter anticodon stem. Notably, phage tRNA repair systems cannot restore tRNAs cleaved by P2–OLD. Our findings unveil a novel tRNA inactivation mechanism involving anticodon arm amputation, providing new insights into the mechanism and specificity of Toprim nucleases and finally resolving a long-standing mystery of P2–Lambda interference.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- New England Biolabs, 240 County Road, Ipswich, MA 01938, United States.
- Department of Microbiology, Harvard Medical School, Boston, MA 02115, United States.
- Center for Biophysics and Quantitative Biology, University of Illinois Urbana-Champaign, Urbana, IL 61801, United States.
- Department of Physics, University of Illinois Urbana-Champaign, Urbana, IL 61801, United States.
ORCID-Profile: Apurva A Govande, Brian D Matibag, Ivan R Corrêa, Hoong Chuin Lim
Förderung
- National Science Foundation Center for Physics of Living Cells
- NIH HHS
- National Science Foundation Science and Technology Center for Quantitative Cell Biology
- NIGMS NIH HHS
- New England Biolabs
- Star Friedman Challenge award
- National Institutes of Health
Zitieren
APA
Govande, A. A., Matibag, B. D., Ünlü, I., Wolf, E. J., Sargen, M. R., Ramsey, B., Kim, S., Helaine, S., Corrêa, I. R., & Lim, H. C. (2025). OLD amputates the anticodon arm of tRNAs during P2–Lambda interference. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf874
Vancouver
Govande AA, Matibag BD, Ünlü I, Wolf EJ, Sargen MR, Ramsey B, et al. OLD amputates the anticodon arm of tRNAs during P2–Lambda interference. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf874
BibTeX
@article{Govande2025,
author = {Govande, Apurva A and Matibag, Brian D and Ünlü, Irem and Wolf, Eric J and Sargen, Molly R and Ramsey, Brooke and Kim, Sangjin and Helaine, Sophie and Corrêa, Ivan R and Lim, Hoong Chuin},
title = {OLD amputates the anticodon arm of tRNAs during P2–Lambda interference},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf874}
}
EUVIMED